Phibro Animal Health (PAHC) Cash from Operations (2013 - 2026)

Phibro Animal Health has reported Cash from Operations for 14 years, with the latest figure at $24.1 million in Q2 2026.

• On a quarterly basis, Cash from Operations rose 13.27% year-over-year to $24.1 million in Q2 2026; TTM through Jun 2026 was $69.0 million, a 13.94% decrease from a year earlier, with the FY2026 full-year figure at $69.0 million, down 13.94% from the prior year.
• Cash from Operations was $24.1 million for Q2 2026 at Phibro Animal Health, up from $16.2 million in the prior quarter.
• The five-year high for Cash from Operations was $43.2 million in Q1 2025, with the low at -$10.7 million in Q3 2022.
• Average Cash from Operations over 5 years is $14.3 million, with a median of $14.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations plunged 379.98% in 2022, then jumped 1367.9% in 2023.
• Over 5 years, Cash from Operations stood at -$2.5 million in 2022, then surged by 1367.9% to $31.6 million in 2023, then sank by 90.25% to $3.1 million in 2024, then surged by 529.13% to $19.4 million in 2025, then rose by 24.5% to $24.1 million in 2026.
• The last three Cash from Operations figures came in at $24.1 million (Q2 2026), $16.2 million (Q1 2026), and $19.4 million (Q4 2025), per Business Quant data.